St. Jude researchers capture the structure of PARP enzymes at work, leading to a new understanding of DNA repair that may aid cancer treatments targeting the process.
St. Jude researchers showed that an inherited variant of the GATA3 gene is tied to minimal residual disease levels and response to therapy for ALL
St. Jude Children’s Research Hospital scientists report that respiratory bacteria aid spread of flu virus .
New guidelines may be warranted for childhood cancer survivors at low and high risk of cardiac late effects.
Reducing neuroinflammation by disrupting a protein involved in recycling cellular components may provide a potential therapeutic approach for treating neurodegeneration and memory loss.
Crispino’s research focuses on acute leukemia in children with Down syndrome and blood cell development
St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences adds Master of Science in Clinical Investigations
New program looking to attract professionals or students interested in clinical research
Research shows that severe hearing loss in childhood cancer survivors is associated with neurocognitive deficits independent of type of therapy.
Behavioral scientist will lead St. Jude community outreach and research programs focused on the prevention of HPV-associated cancers through vaccination
David Rogers named chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital
Rogers replaces the retiring longtime Department Chair Mary Relling
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.